非入侵式健康監測方案
Onalabs 擴大其持續健康科技規模
Onalabs——這家總部設於巴塞隆拿、專注於持續性非入侵健康監測方案的深科技公司——已成功完成一輪超過 930 萬歐元的融資，參與投資者包括西班牙科技轉型協會、1921 Ventures、nPrime、Reig Patrimonia、WA4STEAM 及其他策略投資者。此舉反映市場對公司自家研發的汗液生物感應技術，展現強烈信心。
此筆龐大資金注入，將用於加快 ONASPORT 的產業化及市場拓展——此為公司現已商業化推出的運動表現監測器，可追蹤乳酸、脫水程度、電解質流失及鈉水平等生物標記。資金亦將用於推進 ONAVITAL 的臨床驗證及監管審批，此為一款以醫療保健為重點的裝置，可持續量度血壓、心率、血氧飽和度及體溫。
公司目前與超過十間醫院開展的試點計劃，以及與巴塞隆拿足球會及 Garmin 深化的合作，均展示出其於既有運動及健康生態系統中，獲得真實世界驗證及整合的成效。
英文原文
Onalabs — Barcelona-based deep-tech company specializing in continuous, non-invasive health monitoring solutions — has successfully closed a funding round exceeding €9.3 million, with participation from the Spanish Society for Technological Transformation, 1921 Ventures, nPrime, Reig Patrimonia, WA4STEAM, and other strategic investors. This move signals strong confidence in the company's proprietary sweat-based biosensing technology.
This substantial capital injection will be directed toward accelerating the industrialization and market expansion of ONASPORT — the company's commercially available sports performance monitor that tracks biomarkers including lactate, dehydration, electrolyte loss, and sodium levels. The funding will also advance the clinical validation and regulatory approval of ONAVITAL, a healthcare-focused device that continuously measures blood pressure, heart rate, oxygen saturation, and body temperature.
The company's ongoing pilot programs with more than ten hospitals and its strengthened collaboration with FC Barcelona and Garmin demonstrate real-world validation and integration with established sports and health ecosystems.
- 來源
- Trend Hunter
- 發布
- 2026-08-09
- 品類
- Science
- 出處
- app.dealroom.co